Latest news from the Science Center, our resident companies and the innovation ecosystem.
December 29, 2017 | Beyond The Science Center
Philly Tech’s Most Memorable Moments of 2017
Philadelphia’s tech community has had quite a year. We saw local CEOs stand up in the name of morality, in light of threats to immigration, and tech leaders come forward to speak out about their experiences with sexual harassment. Some companies left the city, while many more doubled down on their commitments to Philly with some impressive exits and funding rounds.
Governor Wolf Announces Approval of Support for 273 Early-Stage, Technology-Oriented Businesses and Entrepreneurs
Today, Governor Tom Wolf announced the approval of Keystone Innovation Zone (KIZ) tax credits for 273 early-stage companies, representing the Wolf Administration’s commitment to Pennsylvania’s technology sector.
More and more Delaware companies are seeking out people with autism because they're finding they have qualities — particularly their attention to detail and fierce loyalty — that make them high performing employees.
Leading Cancer Research Organizations to Host International Conference on Molecular Targets and Cancer Therapeutics in Philadelphia, Oct. 26-30
The American Association for Cancer Research (AACR), the National Cancer Institute (NCI), and the European Organisation for Research and Treatment of Cancer (EORTC) will host their annual International Conference on Molecular Targets and Cancer Therapeutics Oct. 26-30 at the Pennsylvania Convention Center in Philadelphia (1101 Arch Street, Philadelphia, PA 19107).
We are pleased to announce..The Adult Science Fair! The Adult Science Fair is a juried, one-day competition of innovative concepts pertinent to the theme “Urban Sustainability”, with sound scientific or technical basis, positive social-impact, and viability. Sojourn Philly is partnering with NextFab and University City Science Center.
Philly Now a Top 5 City for Life Sciences, Study Says
Professional services and research firm JLL recently released its annual Life Sciences Outlook report, which scores 15 metropolitan areas across the country and Canada on life sciences workforce statistics, funding availability, and other factors.
What’s Militia Hill Ventures’ take on biotech, cancer therapy investment? (Q&A)
Jane Holmes Hollingsworth is a Philadelphia-based serial healthcare entrepreneur with a couple of successful exits under her belt. Teva Pharmaceuticals snapped up migraine pain patch business NuPathe for $114 million and drug developer Auxilium was sold to Endo Pharmaceuticals in a deal valued at $2.6 billion. Since then she has shifted her focus to biotech investment as cofounder and managing partner of Militia Hill Ventures with Joan Lau. Together they hope to create a self-sustaining entrepreneurial ecosystem in the City of Brotherly Love.
Former Phillies slugger Ryan Howard really sees a future for himself among entrepreneurs. Last month, we learned that the former National League MVP and World Series champion is officially a partner at SeventySix Capital. Thursday evening, he sat down for the first time before the public as a VC with fellow SeventySix Capital partner Wayne Kimmel and Villanova Law’s Moorad Center for Sports Law director Andrew Brandt.
In the conference room of a spacious loft office near 30th Street Station, Usman “Oz” Azam and Michael Christiano huddle for a meeting. They’re CEO and chief business officer, respectively, of Tmunity Therapeutics, a start-up launched to commercialize some breakthrough research out of the University of Pennsylvania — a method of reengineering a patient’s own immune system cells so they can destroy cancer tumors.